Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26

Journal of Medicinal Chemistry

Volumn 41, Issue 12, 1998, Pages 2100-2110

  Nguyen, Coralie ^a   Blan, Julià ^b   Mazaleyrat, Jean Paul ^a   Krust, Bernard ^b   Callebaut, Christian ^b   Jacotot, Etienne ^b   Hovanessian, Ara G ^b   Wakselman, Michel ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; DIPEPTIDYL PEPTIDASE IV; DIPHENYL ETHER; ENZYME INHIBITOR; IMINE; PROLINE; PYRROLIDINE DERIVATIVE; QUINONE DERIVATIVE; SULFONIUM DERIVATIVE; TRIFLUOROACETIC ACID;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; ENZYME SPECIFICITY; LYMPHOBLASTOID CELL LINE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD26; ENZYME INHIBITORS; HUMANS; ISOENZYMES; MICE; OLIGOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 14444274339     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970640l     Document Type: Article

References (51)

1. Yaron, A.; Naider, F. Proline-Dependent Structural and Biological Properties of Peptides and Proteins. Crit. Rev. Biochem. Mol. Biol. 1993, 28, 31-81.
2. Fleischer, B. Dipeptidyl peptidase IV (CD26) in Metabolism and in the Immune Response; Springer-Verlag: New York, 1995.
3. 4+ Cells. Science 1993, 262, 2045.
4. Gutheil, W. G.; Subramanyam, M.; Flentke, G. R.; Sanford, D. G.; Munooz, E.; Huber, B. T.; Bachovchin, W. W. Human Imnunodificiency Virus 1 Tat Binds to Dipeptidyl Aminopeptidase IV (CD26): A Possible Mecanism for Tat's Immunosuppressive activity. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 6594-6598.
5. Blanco, J.; Marié, I.; Callebaut, C.; Jacotot, E.; Krust, B.; Hovanessian, A. G. Specific Binding of Adenosine Deaminase but not HIV-1 Transactivator Protein Tat to Human CD26. Exp. Cell. Res. 1996, 225, 102-111.
6. + Individuals. J. Clin. Invest. 1996, 97, 1545-1549.
7. Kameoka, J.; Tanaka, T.; Nojima, Y.; Schlossman, S. F.; Morimoto, C. Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26. Science 1993, 267, 166-169.
8. Torimoto, Y.; Dang, N. H.; Vivier, E.; Tanaka, T.; Schlossman, S. F.; Morimoto, C. Coassociation of CD26 (Dipeptidyl Peptidase IV) with CD45 on the Surface of Human T Lymphocytes. J. Immunol. 1991, 147, 2514-2517.
9. Ansorge, S.; Bühling, F.; Hoffmann, T.; Käne, T.; Neubert, K.; Reinhold, D. DPP IV/CD26 on Human Lymphocytes: functional Roles in Cell Growth and Cytokine Regulation. Dipeptidyl peptidase IV (CD26) in Metabolism and in the Immune Response; Springer-Verlag: New York, 1995; pp 163-184.
10. Fleisher, B. CD26: a Surface Protease Involved in T-Cell Activation. Immunol. Today 1994, 15, 180-184.
11. Tanaka, T.; Kameoka, J.; Yaron, A.; Schlossman, S. F.; Morimoto, C. The Costimulatory Activity of the CD26 Antigen Requires Dpeptidyl Peptidase IV Enzymatic Activity. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 4586-4590.
12. Steeg, C.; Hartwig, U.; Fleisher, B. Unchanged Signaling Capacity of Mutant CD26/Dipeptidylpeptidase IV Molecules Devoid of Enzymatic Activity. Cell Immunol. 1995, 164, 311-315.
13. Rahfeld, J.; Schierhorn, M.; Hartrodt, B.; Neubert, K.; Heins, J. Are Diprotin A (Ile-Pro-Ile) and Diprotin B (Val-Pro-Leu) Inhibitors or Substrates of Dipeptidyl Peptidase IV? Biochim. Biophys. Acta 1991, 1076, 314-316.
14. Schön, E.; Born, L; Demuth, H.-U.; Faust, J.; Neubert, K.; Steinmetzer, T.; Barth, A.; Ansorge, S. Dipeptidyl Peptidase IV in the Immune System. J. Biol. Chem. Hoppe-Seyler 1991, 372, 305-311.
15. Stöckel, A.; Demuth, H.-U.; Neubert, K. Competitive Inhibition of Proline Specific Enzymes by Amino Acid Thioxopyrrolidides and Thiazolidides. Peptides: Chem., Struct. Biol. 1996, 709-710.
16. Augustyns, K. J. L.; Lambeir, A.-M.; Borloo, M.; De Meester, I.; Vedernikova, I.; Vanhoof, G.; Hendriks, D.; Scharpé, S.; Haemers, A. Pyrrolidides: Synthesis and Structure-Activity Relationship as Inhibitors of Dipeptidyl Peptidase IV. Eur. J. Med. Chem. 1997, 32, 301-309.
17. Li, J.; Wilk, E.; Wilk, S. Aminoacylpyrrolidine-2-Nitriles: Potent and Stable Inhibitors of Dipeptidyl-Peptidase IV (CD26). Arch. Biochem. Biophys. 1995, 3, 148-154.
18. Ashworth, D. M.; Atrash, B.; Baker, G. R.; Baxter, A. J.; Jenkins, P. D.; Jones, D. M.; Szelke, M. 2-Cyanopyrrolidides as Potent, Stable Inhibitors of Dipeptidyl Peptidase IV. Bioorg. Med. Chem. Lett. 1996, 6, 1163-1166.
19. Ashworth, D. M.; Atrash, B.; Baker, G. R.; Baxter, A. J.; Jenkins, P. D.; Jones, D. M.; Szelke, M. 4-Cyanothiazolidides as Very Potent, Stable Inhibitors of Dipeptidyl Peptidase IV. Bioorg. Med. Chem. Lett. 1996, 6, 2745-2748.
20. Boduszek, B.; Oleyksyszyn, J.; Kam, C.-M.; Selzler, J.; Smith, R. E.; Powers, J. C. Dipeptide Phosphonates as Inhibitors of Dipeptidyl Peptidase IV. J. Med. Chem. 1994, 37, 3969-3976.
21. Lambeir, A.-M.; Borloo, M.; De Meester, I.; Belyaev, A.; Augustins, K.; Hendricks, D.; Sharpe, S.; Hemers, A. Dipeptide-Derived Diphenyl Phosphonate Esters: Mechanism-Based Inhibitors of Dipeptidyl Peptidase IV. Biochim. Biophys. Acta 1996, 1290, 76-82.
22. Kelly, T. A.; Adams, J.; Bachovchin, W. W.; Barton, R. W.; Campbell, S. J.; Coutts, S. J.; Kennedy, C. A.; Snow, R. J. Immunosuppressive Boronic Acid Dipeptides: Correlation Between Conformation and Activity. J. Am. Chem. Soc. 1993, 115, 12637-12638.
23. Gutheil, G. W.; Bachovchin, W. W. Separation of L-Pro-D-Pro-BoroPro into its Component Diastereomers and Kinetic Analysis of Their Inhibition of Dipeptidyl Peptidase IV. A New Method for the Analysis of Slow, Tight-Binding Inhibition. Biochemistry 1993, 32, 8723-8731.
24. aa-BoroPro Dipeptides. J. Med. Chem. 1996, 39, 2087-2094.
25. Pargellis, C. A.; Campbell, S. J.; Pav, S.; Graham, E. T.; Pittner, T. P. Inhibition of Dipeptidyl Peptidase IV (CD26) by Peptide Boronic Acid Dipeptides. J. Enzyme Inhib. 1997, 11, 151-169.
26. Steinmetzer, T.; Silberring, J.; Mrestani-Klaus, C.; Fittkau, S.; Barth, A.; Demuth, H.-U. Peptidyl Ammonium Methyl Ketones as Substrate Analogue Inhibitors of Proline-Specific Peptidase. J. Enzyme Inhib. 1993, 7, 77-85.
27. Borloo, M.; Augustyns, K.; Belyaev, A.; Lambeir, A.-M.; Goosens, F.; Bollaert, W.; Rajan, P.; Scharpé, S.; Haemers, A. Synthesis and Evaluation of Azaproline Peptides as Potential Inhibitors of Dipeptidyl Peptidase IV and Prolyl Oligopeptidase. Lett. Pept. Sci. 1995, 2, 198-202.
28. Demuth, H.-U.; Baumgrass, R.; Schaper, C.; Fischer, G.; Barth, A. Dipeptidyl Peptidase IV-Inactivation with N-Peptidyl-O-aroyl Hydroxylamines. J. Enzyme Inhib. 1988, 2, 129-142.
29. Demuth, H.-U.; Schlenzig, D.; Schierhorn, A.; Grosche, G.; Chapot-Chartier, M.-P.; Gripon, J. C. Design of [ω-N-(O-Acyl) Hydroxy Amide]Aminodicarboxylic Acid Pyrrolidides as Potent Inhibitors of Proline-Specific Peptidases. FEBS Lett. 1993, 320, 23-27.
30. Welch, J. T.; Lin, J. Fluoroolefin Containing Dipeptide Isosteres as Inhibitors of Dipeptidyi Peptidase IV (CD26). Tetrahedron 1996, 52, 291-304.
31. Welch, J. T.; Lin, J.; Boros, L. G.; DeCorte, B.; Bergrmann, K.; Gimi, R. Fluoroolefin isosteres as peptidomimetics. ACS Symp. Ser. 1996, 639, 129-142.
32. Demuth, H.-U.; Heins, J. Catalytic Mechanism of Dipeptidyl Peptidase IV in Fleisher, B. Dipeptidyl peptidase IV (CD26) in Metabolism and in the Immune Response; Springer-Verlag: New York, 1995; pp 1-35.
33. Ding, X.; Rasmussen, B. F.; Demuth, H.-U.; Ringe, D.; Steinmetz, A. C. U. Nature of the Inactivation of Elastase by N-Peptidyl-O-aroyl Hydroxylamine as a Function of pH. Biochemistry 1995, 34, 7749-7756.
34. Wakselman, M.; Xie, J.; Mazaleyrat, J.-P.; Bogetto, N.; Vilain, A.-C.; Montagne, J.-J.; Reboud-Ravaux, M. New Mechanism-Based Inactivators of Trypsin-like Proteinases. Selective Inactivation of Urokinase by Functionalized Cyclopeptides Incorporating a Sulfoniomethyl-Substitued m-Aminobenzoic Acid Residue. J. Med. Chem. 1993, 36, 1539-1547.
35. Schechter, I.; Berger, A. On the Size of the Active Site in Proteases. I. Papain. Biochem. Biophys. Res. Commun. 1967, 27, 157-162.
36. Jacotot, E.; Callebaut, C.; Blanco, J.; Krust, B.; Neubert, K.; Barth, A.; Hovanessian, A. G. Dipeptidyl-peptidase IV-β, a Novel Form of Cell-Surface-Expressed Protein with Dipeptidyl-Peptidase IV Activity. Eur. J. Biochem. 1996, 239, 248-258.
37. Hamuro, Y.; Geib, S. J.; Hamilton, A. D. Oligoanthranilamides Non-Peptide Subunits that Show Formation of Specific Secondary Structure. J. Am. Chem. Soc. 1996, 118, 7529-7541.
38. Wakselman, M.; Mazaleyrat, J. P.; Xie, J.; Montagne, J. J.; Vilain, A. C.; Reboud-Ravaux, M. Cyclopeptididic Inactivators for Chymotrypsin-Like Proteinases. Eur. J. Med. Chem. 1991, 26, 699-707.
39. Kiso, Y.; Ukawa, K.; Ito, K.; Akita, T. Efficient Removal Protecting group by a "Push-Pull" Mecanism. II. Deprotection of O-Benzyltyrosine with Thioanisole-Trifluoroacetic Acid System Without O to C Rearrangement. Chem. Pharm. Bull. 1980, 28, 673-676.
40. Kiso, Y.; Ukawa, K.; Akita, T. Efficient Removal of N-benzyloxycarbonyl Group by a "Push-Pull" Mechanism Using Thioanisole-Trifluroroacetic Acid, Exemplified by a Synthesis of Met-Enkephalin. J. Chem. Soc., Chem. Commun. 1980, 101-102.
41. Brandt, W.; Lehmann, T.; Thondorf, L; Born, I.; Schutkowski M.; Rahfeld, J.-U.; Neubert, K.; Barth, A. A Model of the Active Site of Dipeptidyl Peptidase IV Predicted by Comparative Molecular Field Analysis and Molecular Modelling Simulations. Int. J. Pept. Protein Res. 1995, 46, 494-507.
42. Brandt, W.; Ludwig, O.; Thondorf, I.; Barth, A. A New Mechanism in Serine Proteases Catalysis Exhibited by Dipeptidyl Peptidase IV (DP IV). Eur. J. Biochem. 1996, 236, 109-114.
43. Hansch, C.; Leo, A.; Taft, R. W. A Survey of Hammett Substituent Constant and Resonnance and Field Parameters. Chem. Rev. 1991, 97, 165-195.
44. Wakselman, M. 1,4- and 1,6-Eliminations From Hydroxy- and Amino-Substitued Benzyl Systems: Chemical and Biochemical Applications. Nouv. J. Chim. 1983, 7, 439-447.
45. Silverman, R. B. Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology; CRC Press: Boca Raton, FL, 1988; Vol. 1, pp 3-22.
46. - cells, by a cyclopeptidic Inhibitor of the DPP IV Activity of CD26. In Peptides 1996; Ramage, R., Epton, R., Eds.; Mayflower Worlwide Ltd., 1998; pp 897-898.
47. Oravecz, Z.; Rodriquez, G.; Koffi, J.; Wang, J.; Ditto, M.; Bou-Habid, D. C.; Lusso, P.; Norcross, M. A. CD26 Expression Correlates with Entry, Replication and Cytopathicity of Monocytotrophic HIV-1 Strains in a T-Cell Line. Nature Med. 1995, 1, 919.
48. + T Cells. Virology 1996, 223, 1-13.
49. + T-Cell Line. In Cellular Peptidases in Immune System and Diseases; Adv. Exp. Med. Biol., Vol. 421; Ansorge, S., Langner, J., Eds.; Plenum Press: New York, 1997, Vol. 421, pp 179-184.
50. Jiang, J. D.; Wilk, S.; Li, J.; Zhang, H.; Bekesi, J. G. Inhibition of Human Immunodeficiency Virus Type 1 Infection in T-Cell Line (CEM) by New Dipeptidyl-Peptidase IV (CD26) Inhibitors. Res. Virol. 1997, 148, 255-266.
51. Blanco, J.; Nguyen, C.; Callebaut, C.; Jacotot, E.; Krust, B.; Mazaleyrat, J. P.; Wakselman, M.; Hovanessian, A. G. DPP IV β: further Characterization and Comparison to DPP IV activity of CD26. Submitted.